FindTrial
Sign In

Effect of hydrogen-oxygen inhalation on cognitive function in patients with Alzheimer's disease

Effect of hydrogen-oxygen inhalation on cognitive function in patients with Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087800
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-12
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Long term hydrogen-oxygen inhalation group:None
Short term hydrogen-oxygen inhalation group:None

Sponsors

Sanbo Brain Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with AD based on past medical history; 2. Age = 65 years old

Exclusion criteria

Exclusion criteria: 1. End stage patients with malignant tumors; 2. Patients who are unable to cooperate with inhalation therapy due to various reasons; 3. Patients who are currently participating in other clinical trials; 4. Known to be intolerant to inhalation therapy.

Design outcomes

Primary

MeasureTime frame
mini-mental state examination (MMSE) score;—

Secondary

MeasureTime frame
Activities of Daily Living (ADLs) score;Quantitative measurement indicators of brain functional status;—

Countries

China

Contacts

Public ContactBaoguo Wang

Sanbo Brain Hospital, Capital Medical University

wangbg@ccmu.edu.cn+86 133 7018 5075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026